CASI Pharmaceuticals
CASI
#10201
Rank
NZ$28.81 M
Marketcap
NZ$1.40
Share price
-1.69%
Change (1 day)
-74.43%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.80. In 2024 the company made an earnings per share (EPS) of NZ-$4.44 a decrease over its 2023 EPS that were of NZ-$3.50.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.654.74%
2024NZ-$4.4426.73%
2023NZ-$3.50-32.89%
2022NZ-$5.2211.9%
2021NZ-$4.67-38.44%
2020NZ-$7.58-8.96%
2019NZ-$8.3350%
2018NZ-$5.5577.78%
2017NZ-$3.125.88%
2016NZ-$2.95-22.73%
2015NZ-$3.82-76.09%
2014NZ-$15.96318.18%
2013NZ-$3.82-71.79%
2012NZ-$13.5365.96%
2011NZ-$8.15-50%
2010NZ-$16.31-18.97%
2009NZ-$20.12-63.64%
2008NZ-$55.333.57%
2007NZ-$53.43-60.56%
2006NZ-$135.4797.22%
2005NZ-$68.69-2.7%
2004NZ-$70.60-45.59%
2003NZ-$129.75-61.8%
2002NZ-$339.64-25.52%
2001NZ-$456.03-21.38%
2000NZ-$580.0513.86%
1999NZ-$509.45149.53%
1998NZ-$204.1698.15%
1997NZ-$103.0410.2%
1996NZ-$93.50